NetworkNewsBreaks – VIVO Cannabis Inc. (TSX: VIV
Post# of 111
VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc. (“ABcann”) and Harvest Medicine Inc. (“Harvest Medicine”), today provided an update on its global medical business, which operates in Canada, Germany and Australia. “One of our top strategic priorities is to focus on the global medical cannabis market, directly servicing tens of thousands of patients and investing in product development initiatives that prioritize high-quality novel products,” Barry Fishman, CEO of VIVO, stated in the news release. “We’ve recently made significant progress on a number of key initiatives, which will help solidify our market presence as a company that is committed to delivering solutions for patients and healthcare professionals on an international scale.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer